ALB and neoplasm: In this study, we developed a novel Nectin-4-targeting Nb drug conjugate comprising two identical Nectin-4 Nbs, an HSA Nb, and vcMMAE, with homogeneous DAR, favorable affinity, and significant tumor uptake.